New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Abstract Proteolysis-targeting chimeras (PROTACs) technology has garnered significant attention over the last 10 years, representing a burgeoning therapeutic approach with the potential to address pathogenic proteins that have historically posed challenges for traditional small-molecule inhibitors....
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2024-05-01
|
| Collection: | Molecular Cancer |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12943-024-02024-9 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|